Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
0.8000
-0.0500 (-5.88%)
Apr 2, 2026, 3:27 PM HKT
HKG:3737 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 174.42 | 167.1 | 164.37 | 381.01 | 233.38 |
Short-Term Investments | - | 32.59 | 25.66 | 23.66 | 15.67 |
Trading Asset Securities | - | - | 2.28 | 14.69 | 8.8 |
Cash & Short-Term Investments | 174.42 | 199.69 | 192.3 | 419.36 | 257.85 |
Cash Growth | -12.65% | 3.84% | -54.14% | 62.64% | -17.10% |
Accounts Receivable | 441.76 | 439.57 | 327.99 | 311.56 | 293.56 |
Other Receivables | - | 8.53 | 8.47 | 6.71 | 13.88 |
Receivables | 441.76 | 448.1 | 336.46 | 318.27 | 307.44 |
Inventory | 280.59 | 345.35 | 330.02 | 322.9 | 268.06 |
Restricted Cash | 26.39 | 2.11 | - | - | - |
Other Current Assets | 72.2 | 18.87 | 15.34 | 30.39 | 24.1 |
Total Current Assets | 995.36 | 1,014 | 874.12 | 1,091 | 857.44 |
Property, Plant & Equipment | 671.14 | 730.44 | 664.12 | 573.6 | 547.31 |
Long-Term Investments | 69.72 | 43.95 | 49.31 | 17.91 | 17 |
Goodwill | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 |
Other Intangible Assets | 8.38 | 11.85 | 14.22 | 15.4 | 18.29 |
Long-Term Deferred Tax Assets | 29.75 | 28.35 | 30.07 | 30.19 | 31.97 |
Other Long-Term Assets | 55.51 | 156.78 | 159.17 | 145.61 | 50.47 |
Total Assets | 1,831 | 1,987 | 1,793 | 1,875 | 1,524 |
Accounts Payable | 261.6 | 295.96 | 190.97 | 189.78 | 120.83 |
Accrued Expenses | - | 44.9 | 46.66 | 89.87 | 59.34 |
Short-Term Debt | - | - | - | 36.03 | 57.24 |
Current Portion of Long-Term Debt | 12.07 | 46.33 | 27.33 | - | - |
Current Portion of Leases | 31.28 | 35.43 | 48.25 | 40.21 | 37.87 |
Current Income Taxes Payable | 36.16 | 44.91 | 39.58 | 30.76 | 27.71 |
Current Unearned Revenue | 2.3 | 13.79 | 33.13 | 134.97 | 29.81 |
Other Current Liabilities | 278.14 | 250.26 | 222.68 | 209.64 | 168.02 |
Total Current Liabilities | 621.54 | 731.56 | 608.61 | 731.25 | 500.83 |
Long-Term Debt | 36 | 38.27 | 22.68 | - | - |
Long-Term Leases | 50.66 | 68.57 | 76.59 | 94.62 | 80.62 |
Long-Term Unearned Revenue | 5.43 | 7.91 | 11.87 | 15.84 | 15.43 |
Long-Term Deferred Tax Liabilities | 18.08 | 19.26 | 19.55 | 27.59 | 26.06 |
Total Liabilities | 731.71 | 865.58 | 739.3 | 869.31 | 622.94 |
Common Stock | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 |
Additional Paid-In Capital | - | 63.59 | 86.73 | 202.87 | 202.87 |
Retained Earnings | - | 1,022 | 927.28 | 764.51 | 658.12 |
Comprehensive Income & Other | 1,088 | 23.59 | 27.66 | 28.75 | 30.9 |
Total Common Equity | 1,095 | 1,117 | 1,049 | 1,003 | 898.74 |
Minority Interest | 5.05 | 5.02 | 4.82 | 2.97 | 2.43 |
Shareholders' Equity | 1,100 | 1,122 | 1,053 | 1,006 | 901.17 |
Total Liabilities & Equity | 1,831 | 1,987 | 1,793 | 1,875 | 1,524 |
Total Debt | 130.01 | 188.6 | 174.86 | 170.86 | 175.74 |
Net Cash (Debt) | 44.41 | 11.09 | 17.45 | 248.5 | 82.1 |
Net Cash Growth | 300.50% | -36.45% | -92.98% | 202.67% | -33.32% |
Net Cash Per Share | 0.05 | 0.01 | 0.02 | 0.29 | 0.10 |
Filing Date Shares Outstanding | 863.6 | 863.6 | 863.6 | 863.6 | 863.6 |
Total Common Shares Outstanding | 863.6 | 863.6 | 863.6 | 863.6 | 863.6 |
Working Capital | 373.83 | 282.56 | 265.51 | 359.67 | 356.61 |
Book Value Per Share | 1.27 | 1.29 | 1.21 | 1.16 | 1.04 |
Tangible Book Value | 1,085 | 1,103 | 1,033 | 985.95 | 878.82 |
Tangible Book Value Per Share | 1.26 | 1.28 | 1.20 | 1.14 | 1.02 |
Buildings | - | 271.57 | 279.83 | 268.41 | 194.41 |
Machinery | - | 268.92 | 250.64 | 221.23 | 181.43 |
Construction In Progress | - | 221.69 | 110.59 | 29.86 | 116.37 |
Leasehold Improvements | - | 192.2 | 184.08 | 187.73 | 164.24 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.